These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11266404)

  • 41. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates.
    Johnstone EC; Owens DG; Bydder GM; Colter N; Crow TJ; Frith CD
    Psychol Med; 1989 Feb; 19(1):91-103. PubMed ID: 2727213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expected value and prediction error abnormalities in depression and schizophrenia.
    Gradin VB; Kumar P; Waiter G; Ahearn T; Stickle C; Milders M; Reid I; Hall J; Steele JD
    Brain; 2011 Jun; 134(Pt 6):1751-64. PubMed ID: 21482548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain imaging in late-life schizophrenia and related psychoses.
    Lesser IM; Miller BL; Swartz JR; Boone KB; Mehringer CM; Mena I
    Schizophr Bull; 1993; 19(4):773-82. PubMed ID: 8303226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The assessment of intelligence function of aged chronic schizophrenia.
    Fukunishi I; Okabe S; Nakagawa T; Hosokawa K
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):503-9. PubMed ID: 2074609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conclusions: late-life schizophrenia.
    Schultz SK
    Harv Rev Psychiatry; 2001; 9(2):84-7. PubMed ID: 11266406
    [No Abstract]   [Full Text] [Related]  

  • 47. The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia.
    el-Mallakh RS; Kirch DG; Shelton R; Fan KJ; Pezeshkpour G; Kanhouwa S; Wyatt RJ; Kleinman JE
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):383-6. PubMed ID: 1821257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both?
    Harrison PJ
    Neurodegeneration; 1995 Mar; 4(1):1-12. PubMed ID: 7600178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Capgras syndrome in a very late onset, treatment resistant schizophrenia.
    Ain MK; Rosdinom R; Raynuha M
    Int Psychogeriatr; 2015 Sep; 27(9):1573-5. PubMed ID: 25794136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI changes in schizophrenia in late life: a preliminary controlled study.
    Keshavan MS; Mulsant BH; Sweet RA; Pasternak R; Zubenko GS; Krishnan RR
    Psychiatry Res; 1996 Mar; 60(2-3):117-23. PubMed ID: 8723302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics.
    Murphy GM; Lim KO; Wieneke M; Ellis WG; Forno LS; Hoff AL; Nordahl T
    Biol Psychiatry; 1998 Feb; 43(3):205-9. PubMed ID: 9494702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late paraphrenia: a variant of schizophrenia manifest in late life or an organic clinical syndrome? A review of recent evidence.
    Roth M; Kay DW
    Int J Geriatr Psychiatry; 1998 Nov; 13(11):775-84. PubMed ID: 9850874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia.
    Arnold SE; Smutzer GS; Trojanowski JQ; Moberg PJ
    Ann N Y Acad Sci; 1998 Nov; 855():762-75. PubMed ID: 9929682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional neuropathology in schizophrenia: where are we? Where are we going?
    Shapiro RM
    Schizophr Res; 1993 Oct; 10(3):187-239. PubMed ID: 7903156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neuro-imaging in schizophrenia].
    D'Amato T; Rochet T; Marie-Cardine M; Dalery J
    Ann Med Psychol (Paris); 1993 Apr; 151(4):332-4; discussion 334-5. PubMed ID: 8285503
    [No Abstract]   [Full Text] [Related]  

  • 56. Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia.
    Wolf RC; Vasic N; Sambataro F; Höse A; Frasch K; Schmid M; Walter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1464-73. PubMed ID: 19666074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Schizophrenia in children and adolescents: relevance and differentiation from adult schizophrenia].
    Androutsos Ch
    Psychiatriki; 2012 Jun; 23 Suppl 1():82-93. PubMed ID: 22796977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing cognitive function in schizophrenics and patients with Alzheimer's disease.
    Mohs RC
    Schizophr Res; 1995 Sep; 17(1):115-21. PubMed ID: 8541244
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects.
    Friedman JI; Davis KL; Chang L; Ernst T; Tsopelas ND; Zhong K
    Schizophr Res; 2008 Mar; 100(1-3):356-8. PubMed ID: 18042350
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuropathology of schizophrenia: a mini review.
    Iritani S
    Neuropathology; 2007 Dec; 27(6):604-8. PubMed ID: 18021384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.